Difference between revisions of "Team:UNC-Chapel Hill/Project"

Revision as of 01:38, 19 September 2015

Tri Color Glucose Sensing System

Abstract

This project introduces a novel glucose sensing system in which glucose-responsive promoters drive the expression of three reporter chromoproteins. We designed four novel glucose-sensitive promoters and tested their ability to drive expression of reporter chromoproteins at various glucose concentrations. In conjunction with existing glucose sensitive promoters from the Parts Registry, we used our novel promoters to design a biological device that expresses different combinations of the three different chromoproteins in response to glucose in Escherichia coli. As such, this device can detect a larger dynamic range of concentrations of selected molecules (e.g., glucose). Our project aims to provide a cheaper alternative for diabetics than current, more expensive, glucose-monitoring systems. While driven by this initial problem, continuing work has shown that our approach may have its greatest potential as a more general molecular sensing platform, capable of being easily customized for the sensing of a broad range of relevant compounds.

Methodology

Overall Experimental Design

We

Results

Shown here are the different intensities of yellow chromoprotein expression with respect to varying glucose concentrations. The parts were grown in LB media of varying glucose concentration ranging from 3mg/dL to 500 mg/dL. These values of glucose concentration were chosen because they were within the range of blood glucose levels. MLC's were expected to behave as glucose inducible promoters; however, from our results, the data appears to show the expression of the chromoprotein decrease as the concentration of glucose increases. All three MLC's seemed to behave in the same fashion and are all sensitive to glucose levels.

This picture shows a clearer image of the decreasing yellow color intensity in MLC 4 as glucose concentration is increased. Since the LB media itself is yellow in color, it is diffucult to distinguish between the chromoprotein and the background color of the culture. The decrease in expression can be more clearly seen in the absorbance vs. concentration plots below.

Type 2 diabetes is characterized by the body being inefficient in its use of insulin (insulin resistance) which causes the pancreas to decrease insulin production (insulin deficiency). Our potential solution for this is to have pseudo L cells release GLP-1 to promote insulin production. GLP-1 is an incretin. Incretins are a group of gastrointestinal hormones that stimulate a decrease in blood glucose levels. GLP-1 has been shown to promote insulin production and also to decrease glucagon production. Glucagon is a peptide hormone produced by alpha cells of the pancreas that raises the concentration of glucose in the bloodstream.

References

Thank You

Lorem ipsum ad his scripta blandit partiendo, eum fastidii accumsan euripidis in, eum liber hendrerit an. Qui ut wisi vocibus suscipiantur, quo dicit ridens inciderint id. Quo mundi lobortis reformidans eu, legimus senserit definiebas an eos. Eu sit tincidunt incorrupte definitionem, vis mutat affert percipit cu, eirmod consectetuer signiferumque eu per. In usu latine equidem dolores. Quo no falli viris intellegam, ut fugit veritus placerat per.

@@ Line 58: / Line 58: @@
 <td align="center" width="10%" height ="35px"
 onMouseOver="this.bgColor='#A1DBB2'" onMouseOut="this.bgColor='#56A0D3'" bgColor=#56A0D3>
-<a href="#absorbance" style="text-decoration:none;color:#ffffff">Absorbance Data</a> </td>
+<a href="#absorbance" style="text-decoration:none;color:#ffffff">Data</a> </td>
 </td>
@@ Line 111: / Line 111: @@
 <h2 style="color:#56A0D3"> Overall Experimental Design</h2>
 <p style = "text-align: center"><img src = "https://static.igem.org/mediawiki/2015/3/34/Unc-methodology.png" width = "600px"></p>
+<p>We
@@ Line 127: / Line 127: @@
 <td width="100%"  height="4px"  bgColor="#FFFFFF" >
-<p id="type2" style="color:#56A0D3; font-size:30px"> Type Two Diabetes</p>
+<p id="results" style="color:#56A0D3; font-size:30px">Results</p>
-<h2 style="color:#56A0D3"> Solution </h2>
+<h2 style="color:#56A0D3"> Results</h2>
+<p style = "text-align: center"><img src = "https://static.igem.org/mediawiki/2015/e/e9/Unc-cuvettes1.png" width = "900px"></p>
+<p> Shown here are the different intensities of yellow chromoprotein expression with respect to varying glucose concentrations. The parts were grown in LB media of varying glucose concentration ranging from 3mg/dL to 500 mg/dL. These values of glucose concentration were chosen because they were within the range of blood glucose levels. MLC's were expected to behave as glucose inducible promoters; however, from our results, the data appears to show the expression of the chromoprotein decrease as the concentration of glucose increases. All three MLC's seemed to behave in the same fashion and are all sensitive to glucose levels.</p>
+<p style = "text-align: center"><img src = "https://static.igem.org/mediawiki/2015/e/e1/Unc-cuvettes.png" width = "900px"></p>
+<p> This picture shows a clearer image of the decreasing yellow color intensity in MLC 4 as glucose concentration is increased. Since the LB media itself is yellow in color, it is diffucult to distinguish between the chromoprotein and the background color of the culture.  The decrease in expression can be more clearly seen in the absorbance vs. concentration plots below. </p>
 <p>Type 2 diabetes is characterized by the body being inefficient in its use of insulin (insulin resistance) which causes the pancreas to decrease insulin production (insulin deficiency). Our potential solution for this is to have pseudo L cells release GLP-1 to promote insulin production. GLP-1 is an incretin. Incretins are a group of gastrointestinal hormones that stimulate a decrease in blood glucose levels. GLP-1 has been shown to promote insulin production and also to decrease glucagon production. Glucagon is a peptide hormone produced by alpha cells of the pancreas that raises the concentration of glucose in the bloodstream.</p>